Synopsis
0
VMF
0
FDA Orange Book
DRUG PRODUCT COMPOSITIONS
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
54
PharmaCompass offers a list of Gliclazide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Gliclazide manufacturer or Gliclazide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Gliclazide manufacturer or Gliclazide supplier.
PharmaCompass also assists you with knowing the Gliclazide API Price utilized in the formulation of products. Gliclazide API Price is not always fixed or binding as the Gliclazide Price is obtained through a variety of data sources. The Gliclazide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Gliclazide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Gliclazide, including repackagers and relabelers. The FDA regulates Gliclazide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Gliclazide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Gliclazide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Gliclazide supplier is an individual or a company that provides Gliclazide active pharmaceutical ingredient (API) or Gliclazide finished formulations upon request. The Gliclazide suppliers may include Gliclazide API manufacturers, exporters, distributors and traders.
click here to find a list of Gliclazide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Gliclazide DMF (Drug Master File) is a document detailing the whole manufacturing process of Gliclazide active pharmaceutical ingredient (API) in detail. Different forms of Gliclazide DMFs exist exist since differing nations have different regulations, such as Gliclazide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Gliclazide DMF submitted to regulatory agencies in the US is known as a USDMF. Gliclazide USDMF includes data on Gliclazide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Gliclazide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Gliclazide suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Gliclazide Drug Master File in Japan (Gliclazide JDMF) empowers Gliclazide API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Gliclazide JDMF during the approval evaluation for pharmaceutical products. At the time of Gliclazide JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Gliclazide suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Gliclazide Drug Master File in Korea (Gliclazide KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Gliclazide. The MFDS reviews the Gliclazide KDMF as part of the drug registration process and uses the information provided in the Gliclazide KDMF to evaluate the safety and efficacy of the drug.
After submitting a Gliclazide KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Gliclazide API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Gliclazide suppliers with KDMF on PharmaCompass.
A Gliclazide CEP of the European Pharmacopoeia monograph is often referred to as a Gliclazide Certificate of Suitability (COS). The purpose of a Gliclazide CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Gliclazide EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Gliclazide to their clients by showing that a Gliclazide CEP has been issued for it. The manufacturer submits a Gliclazide CEP (COS) as part of the market authorization procedure, and it takes on the role of a Gliclazide CEP holder for the record. Additionally, the data presented in the Gliclazide CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Gliclazide DMF.
A Gliclazide CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Gliclazide CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Gliclazide suppliers with CEP (COS) on PharmaCompass.
A Gliclazide written confirmation (Gliclazide WC) is an official document issued by a regulatory agency to a Gliclazide manufacturer, verifying that the manufacturing facility of a Gliclazide active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Gliclazide APIs or Gliclazide finished pharmaceutical products to another nation, regulatory agencies frequently require a Gliclazide WC (written confirmation) as part of the regulatory process.
click here to find a list of Gliclazide suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Gliclazide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Gliclazide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Gliclazide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Gliclazide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Gliclazide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Gliclazide suppliers with NDC on PharmaCompass.
Gliclazide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Gliclazide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Gliclazide GMP manufacturer or Gliclazide GMP API supplier for your needs.
A Gliclazide CoA (Certificate of Analysis) is a formal document that attests to Gliclazide's compliance with Gliclazide specifications and serves as a tool for batch-level quality control.
Gliclazide CoA mostly includes findings from lab analyses of a specific batch. For each Gliclazide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Gliclazide may be tested according to a variety of international standards, such as European Pharmacopoeia (Gliclazide EP), Gliclazide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Gliclazide USP).
